资讯

U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental ...